pyrroles formation via dehygronative deamination process.2e
Compared with the commonly used methods which em-
ployed expensive metal catalysts and stoichiometric metal
oxidants,3 dioxygen-copper systems are more attractive
for C-H bond activation.4 Herein, we report an interesting
and unprecedented result for a three-component reaction of
2-alkynylbenzaldehyde, sulfonohydrazide, and tertiary
amine, which generates H-pyrazolo[5,1-a]isoquinolines in
good yields. In the reaction process, the tertiary amine is
activated via oxidation of an aliphatic C-H bond catalyzed
by a dioxygen-copper system.
The development of new strategies with a high efficiency
has been an important goal as well as a great challenge in
synthetic chemistry.5 The multicomponent reaction is an
attractive device since it can serve as a powerful tool for the
assembly of complex structures.6 Currently, much atten-
tion has been paid to this exciting research area, especially
for construction of natural product-like compounds. It is
well recognized that the isoquinoline nucleus is one of the
most abundant structural motifs found in natural products
and biologically active molecules.7 Additionally, many com-
pounds possessing this subunit exhibit a broad range of
pharmacological activity, including antifungal, antimalarial,
antihypertensive, antitumor, and antihistaminic activity.8-11
For instance, the opium alkaloid papaverine is discovered to
be useful as a vasodilator.10 Decumbenine B is efficient for
inhibition of spontaneous contraction of the intestine.11
Therefore, extensive studies have been performed toward
the design and synthesis of this ring system.12,13 For example,
Larock, Takemoto, and Yamamoto reported isoquinoline
generation via transition-metal catalyzed cyclization of
ortho-alkynylaryl aldimines, respectively.13 We also devel-
oped methods for formation of diverse isoquinolines starting
from 2-alkynylbenzaldehyde and related compounds.14
Among the compounds synthesized, it was found that H-
pyrazolo[5,1-a]isoquinoline was effective for inhibition
of PTP1B (protein tyrosine phosphatase 1 B, IC50 1.75
μg/mL).14a With an expectation to find better hits, it is highly
desirable to generate functionalized fused isoquniolines using
diversity-oriented synthesis.
In our previous reports,14,15 we demonstrated that N0-(2-
alkynylbenzylidene)hydrazide was the key species in tan-
dem reactions for construction of N-heterocycles. During
our studies, we recognized that N0-(2-alkynylbenzylidene)-
hydrazide could be easily cyclized to isoquinolinium-2-
ylamide via 6-endo-cyclization catalyzed by silver salts or
promoted by electrophiles.14,15 Thus, further cycloaddi-
tions might occur under suitable conditions. Indeed, a series
of substrates including dimethyl acetylenedicarboxylate,15a
phenylacetylene,15b,c and methyl acrylate14c have been
(4) For selected examples, see: (a) Punniyamurthy, T.; Velusamy, S.;
Iqbal, J. Chem. Rev. 2005, 105, 2329. (b) Stahl, S. S. Angew. Chem., Int.
Ed. 2004, 43, 3400. (c) Tsuchimoto, T.; Ozawa, Y.; Negoro, R.; Shirakawa,
E.; Kawakami, Y. Angew. Chem., Int. Ed. 2004, 43, 4231. (d) Phipps, R. J.;
Grimster, N. P.; Gaunt, M. J. J. Am. Chem. Soc. 2008, 130, 8172. (e) Li, Z. P.;
Li, C. J. J. Am. Chem. Soc. 2005, 127, 6968. (f) Zhang, C.; Jiao, N. J. Am.
Chem. Soc. 2010, 132, 28. (g) Chen, X.; Hao, X. S.; Goodhue, C. E.; Yu, J. Q.
J. Am. Chem. Soc. 2006, 128, 6790. (h) Hamada, T.; Ye, X.; Stahl, S. S.
J. Am. Chem. Soc. 2008, 130, 833. (i) King, A. E.; Brunold, T. C.; Stahl, S. S.
(9) (a) Reddy, M. V. R.; Rao, M. R.; Rhodes, D.; Hansen, M. S. T.;
Rubins, K.; Bushman, F. D.; Venkateswarlu, Y.; Faulkner, D. J. J. Med.
Chem. 1999, 42, 1901. (b) Aubry, A.; Pan, X.-S.; Fisher, L. M.; Jarlier, V.;
Cambau, E. Antimicrob. Agents Chemother. 2004, 48, 1281. (c) Marco, E.;
Laine, W.; Tardy, C.; Lansiaux, A.; Iwao, M.; Ishibashi, F.; Bailly, C.; Gago,
F. J. Med. Chem. 2005, 48, 3796. (d) Bailly, C. Curr. Med. Chem.: Anti-
Cancer Agents 2004, 4, 363.
(10) (a) Karatas, A.; Gokce, F.; Demir, S.; Ankarali, S. Neurosci.
Lett. 2008, 445, 58. (b) Smith, W. S.; Dowd, C. F.; Johnston, S. C.; Ko, N. U.;
DeArmond, S. J.; Dillon, W. P.; Setty, D.; Lawton, M. T.; Young, W. L.;
Higashida, R. T.; Halbach, V. V. Stroke 2004, 35, 2518.
ꢀ
J. Am. Chem. Soc. 2009, 131, 5044. (j) Basle, O.; Li, C.-J. Green Chem.
ꢀ
ꢀ
2007, 9, 1047. (k) Basle, O.; Li, C.-J. Org. Lett. 2008, 10, 3661. (l) Basle, O.;
ꢀ
Li, C.-J. Chem. Commun. 2009, 27, 4124. (m) Basle, O.; Borduas, N.;
Dubois, P.; Chapuzet, J.-M.; Chan, T.-K.; Lessard, J.; Li, C.-J. Chem.;Eur.
J. 2010, 16, 8162. (n) Tian, J.-S.; Loh, T.-P. Angew. Chem., Int. Ed. 2010,
49, 8417. (o) He, H. F.; Wang, Z. J.; Bao, W. L. Adv. Synth. Catal. 2010, 352,
2905. (p) Brasche, G.; Buchwald, S. L. Angew. Chem., Int. Ed. 2008, 47,
1932. (q) Huber, S. M.; Ertem, M. Z.; Aquilante, F.; Gagliardi, L.; Tolman,
W. B.; Cramer, C. J. Chem.;Eur. J. 2009, 15, 4886. (r) Tang, B.-X.; Song,
R.-J.; Wu, C.-Y.; Liu, Y.; Zhou, M.-B.; Wei, W.-T.; Deng, G.-B.; Yin, D.-L.;
Li, J.-H. J. Am. Chem. Soc. 2010, 132, 8900. (s) Chiba, S.; Zhang, L.; Lee,
J.-Y. J. Am. Chem. Soc. 2010, 132, 7266. (t) Wang, H.; Wang, Y.; Peng, C.;
Zhang, J.; Zhu, Q. J. Am. Chem. Soc. 2010, 132, 13217. (u) King, A. E.;
Huffman, L. M.; Casitas, A.; Costas, M.; Ribas, X.; Stahl, S. S. J. Am. Chem.
Soc. 2010, 132, 12068.
(11) (a) Xu, X.-Y.; Qin, G.-W.; Xu, R.-S.; Zhu, X.-Z. Tetrahedron
1998, 54, 14179. (b) Zhang, J.; Zhu, D.; Hong, S. Phytochemistry 1995, 39,
435. (c) Wada, Y.; Nishida, N.; Kurono, N.; Ohkuma, T.; Orito, K. Eur. J.
Org. Chem. 2007, 4320and references therein.
(12) For selected examples, see: (a) Balasubramanian, M.; Keay,
J. G. Isoquinoline Synthesis. In Comprehensive Heterocyclic Chemistry
II; McKillop, A. E., Katrizky, A. R., Rees, C. W., Scrivem, E. F. V., Eds.;
Elsevier: Oxford, 1996; Vol. 5, p 245. (b) For a review on the synthesis of
isoquinoline alkaloid, see: Chrzanowska, M.; Rozwadowska, M. D. Chem.
Rev. 2004, 104, 3341. (c) Niu, Y.-N.; Yan, Z.-Y.; Gao, G.-L.; Wang, H.-L.;
Shu, X.-Z.; Ji, K.-G.; Liang, Y.-M. J. Org. Chem. 2009, 74, 2893. (d) Yang,
Y.-Y.; Shou, W.-G.; Chen, Z.-B.; Hong, D.; Wang, Y.-G. J. Org. Chem. 2008,
73, 3928. (e) Fischer, D.; Tomeba, H.; Pahadi, N. K.; Patil, N. T.; Huo, Z.;
Yamamoto, Y. J. Am. Chem. Soc. 2008, 130, 15720. (f) Movassaghi, M.;
Hill, M. D. Org. Lett. 2008, 10, 3485. (g) Su, S.; Porco, J. A. Org. Lett. 2007,
9, 4983.
(13) For selected examples, see: (a) Roy, S.; Neuenswander, B.; Hill,
D.; Larock, R. C. J. Comb. Chem. 2009, 11, 1061 and references therein.
(b) Obika, S.; Kono, H.; Yasui, Y.; Yanada, R.; Takemoto, Y. J. Org. Chem.
2007, 72, 4462 and references therein. (c) Asao, N.; Yudha, S.; Nogami, T.;
Yamamoto, Y. Angew. Chem., Int. Ed. 2005, 44, 5526. (d) Yanada, R.;
Obika, S.; Kono, H.; Takemoto, Y. Angew. Chem., Int. Ed. 2006, 45, 3822.
(14) For selected recent examples, see: (a) Chen, Z.; Wu, J. Org. Lett.
2010, 12, 4856. (b) Chen, Z.; Yu, X.; Wu, J. Chem. Commun. 2010, 46, 6356.
(c) Ye, S.; Yang, X.; Wu, J. Chem. Commun. 2010, 46, 5238. (d) Ye, S.; Gao,
K.; Wu, J. Adv. Synth. Catal. 2010, 352, 1746. (e) Yu, X.; Ye, S.; Wu, J. Adv.
Synth. Catal. 2010, 352, 2050.
(5) Trost, B. M. Science 1991, 254, 1471.
(6) For selected examples of multicomponent reactions, see: (a)
Multicomponent Reactions; Zhu, J.; Bienayme, H., Eds.; Wiley-VCH:
Weinheim, Germany, 2005. (b) Ramon, D. J.; Yus, M. Angew. Chem., Int.
Ed. 2005, 44, 1602. (c) Nair, V.; Rajesh, C.; Vinod, A. U.; Bindu, S.;
Sreekenth, A. R.; Balagopal, L. Acc. Chem. Res. 2003, 36, 899. (d) Orru,
R. V. A.; Greef, M. D. Synthesis 2003, 1471. (e) Balme, G.; Bossharth, E.;
Monteiro, N. Eur. J. Org. Chem. 2003, 4101. (f) Domling, A.; Ugi, I.
Angew. Chem., Int. Ed. 2000, 39, 3168. (g) Bienayme, H.; Hulme, C.;
Oddon, G.; Schmitt, P. Chem.;Eur. J. 2000, 6, 3321. (h) Weber, L.; Illgen,
K.; Almstetter, M. Synlett 1999, 366. (i) Ugi, I.; Domling, A.; Werner, B.
J. Heterocycl. Chem. 2000, 37, 647. (j) Zhu, J. Eur. J. Org. Chem. 2003,
1133. (k) Hulme, C.; Gore, V. Curr. Med. Chem. 2003, 10, 51.
(7) Bentley, K. W. The Isoquinoline Alkaloids; Hardwood Academic:
Amsterdam, 1998; Vol. 1.
(8) (a) Fish, P. V.; Barber, C. G.; Brown, D. G. J. Med. Chem. 2007,
50, 2341. (b) Ukita, T.; Nakamura, Y.; Kubo, A. J. Med. Chem. 2001, 44,
2204. (c) Phillipson, J. D.; Roberts, M. F.; Zenk, M. H., Eds. The Chemistry
and Biology of Isoquinoline Alkaloids; Springer Verlag: Berlin, 1985. (d)
Kartsev, V. G. Med. Chem. Res. 2004, 13, 325. (e) Menachery, M. D.;
Lavanier, G. L.; Wetherly, M. L.; Guinaudeau, H.; Shamma, M. J. Nat. Prod.
1986, 49, 745. (f) Baker, B. J. Alkaloids: Chem. Biol. Perspect. 1996, 10,
357. (g) Lundstroem, J. Alkaloids 1983, 21, 255. (h) Croisy-Delcey, M.;
Croisy, A.; Carrez, D.; Huel, C.; Chiaroni, A.; Ducrot, P.; Bisagni, E.; Jin, L.;
Leclercq, G. Bioorg. Med. Chem. 2000, 8, 2629.
(15) (a) Chen, Z.; Ding, Q.; Yu, X.; Wu, J. Adv. Synth. Catal. 2009,
351, 1692. (b) Chen, Z.; Yang, X.; Wu, J. Chem. Commun. 2009, 3469. (c)
Chen, Z.; Su, M.; Yu, X.; Wu, J. Org. Biomol. Chem. 2009, 7, 4641. (d) Yu,
X.; Yang, X.; Wu, J. Org. Biomol. Chem. 2009, 7, 4526.
Org. Lett., Vol. 13, No. 4, 2011
713